Effects of Resistin on Neutrophil Function
NCT03626870 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2024-12-10
Summary
To assess the effect of resistin on neutrophil migration and intracellular bacterial killing
Conditions
Sponsors & Collaborators
-
Milton S. Hershey Medical Center
lead OTHER
Principal Investigators
-
Anthony Bonavia, MD · Penn State Milton S Hershey Med Ctr
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2019-09-01
- Completion
- 2019-09-01
Countries
- United States
Study Locations
More Related Trials
-
Understanding COVID-19 Vaccine Immunity in Tissue and Blood
NCT05682625 ·Status: WITHDRAWN
-
Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1
NCT03630809 ·Status: TERMINATED ·Phase: PHASE2
-
Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients
NCT00929019 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Immune Resistance Interrogation Study
NCT04243720 ·Status: RECRUITING
-
Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)
NCT02419170 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
NCT01096602 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Therapy in Treating Patients With Advanced Cancer
NCT00005956 ·Status: COMPLETED ·Phase: NA
-
In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides
NCT02159937 ·Status: COMPLETED
-
Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma
NCT00683670 ·Status: COMPLETED ·Phase: PHASE1
-
Sargramostim for Myeloid Dendritic Cell Deficiency
NCT03063242 ·Status: TERMINATED ·Phase: PHASE2
-
Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis
NCT06040918 ·Status: COMPLETED ·Phase: PHASE1
-
Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
NCT00346619 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection
NCT04362865 ·Status: COMPLETED
-
Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History
NCT06821685 ·Status: RECRUITING ·Phase: PHASE1
-
Vaccine Therapy in Treating Patients With Kidney Cancer
NCT00014131 ·Status: TERMINATED ·Phase: PHASE1
-
Hyporesponsiveness of Natural Killer Cells and a Dysfunctional Inflammatory Response in Critically Ill Patients
NCT02565589 ·Status: COMPLETED
-
Immune Response to the COVID-19 Vaccine
NCT04936997 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer
NCT01897207 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
NCT00001158 ·Status: COMPLETED
-
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
NCT05325632 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia
NCT05000801 ·Status: RECRUITING ·Phase: NA
-
TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
NCT02065362 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Evaluation of Immune Signaling Networks in Healthy Human Volunteers
NCT01882582 ·Status: COMPLETED
-
T Cell Response in Hypersensitivity Syndrome
NCT00213447 ·Status: COMPLETED
-
Myeloid Suppressors in Inflammation
NCT01224223 ·Status: COMPLETED